Exact Sciences Corp (NAS:EXAS)
$ 53.52 2.52 (4.94%) Market Cap: 9.88 Bil Enterprise Value: 11.78 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 78/100

Exact Sciences Corp at Jefferies London Healthcare Conference Transcript

Nov 15, 2023 / 02:30PM GMT
Release Date Price: $63.12 (-0.54%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

We'll go ahead and get started. Good afternoon, and welcome to the Jefferies 2023 London Healthcare Conference. I'm Brandon Couillard. I cover life science tools and diagnostics sector here at the firm. It is a great pleasure to have Exact Sciences back at the conference again this year. Joining us for this conversation, CEO, Kevin Conroy; as well as EVP of Human Resources, Sarah Condella.

Sarah, Kevin, thanks so much for being here.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO

Well, Brandon and Jefferies, thank you for having us. It's always one of our favorite conferences to attend, and we really look forward to the conversation.

Questions & Answers

Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Maybe just to kick things off, Kevin, I mean, in the third quarter, very solid 23% organic growth. Cologuard up 30% on a 30% comp. You posted positive adjusted EBITDA, again, for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot